These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1059707)

  • 1. Type-specific action of vibriocidal antibody on Vibrio cholerae.
    Pykett AH; Preston NW
    J Hyg (Lond); 1975 Dec; 75(3):399-406. PubMed ID: 1059707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.
    Preston NW
    Epidemiol Infect; 1993 Jun; 110(3):489-97. PubMed ID: 8519314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.
    Qadri F; Mohi G; Hossain J; Azim T; Khan AM; Salam MA; Sack RB; Albert MJ; Svennerholm AM
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):685-8. PubMed ID: 8574829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on V. cholerae anti-antibodies (agglutinating and vibriocidal) in patients affected by cholera-like gastroenteritis. Studies performed during the cholera epidemic occurred in Apulia in August-September 1973].
    Barbuti S; Iandolo E; Rizzo G; Leogrande G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):449-59. PubMed ID: 1084731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
    Lycke N; Svennerholm AM; Holmgren J
    Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
    Losonsky GA; Lim Y; Motamedi P; Comstock LE; Johnson JA; Morris JG; Tacket CO; Kaper JB; Levine MM
    Clin Diagn Lab Immunol; 1997 May; 4(3):264-9. PubMed ID: 9144361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX.
    Barua D; Watanabe Y
    J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serological properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1983 Jul; 129(7):2199-206. PubMed ID: 6415227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae.
    Das M; Chopra AK; Cantu JM; Peterson JW
    FEMS Immunol Med Microbiol; 1998 Dec; 22(4):303-8. PubMed ID: 9879921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
    Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
    J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.
    Wade TK; Wade WF
    Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic O antigen relationship of Brucella and Vibrio cholerae.
    Feeley JC
    J Bacteriol; 1969 Sep; 99(3):645-9. PubMed ID: 5370272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.